Having trouble viewing this email? View in your browser.

13 November 2018

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


European Commission's publication on vaccination

European Commission has published new reports and other documents on vaccination.

Vaccination policy is a competence of national authorities, but the European Commission assists EU countries in coordinating their policies and programmes. The Commission proposed in April 2018 a Council Recommendation to strengthen the EU cooperation on vaccine-preventable diseases. The initiative aims to tackle vaccine hesitancy, improve coordination on vaccine procurement, support research and innovation, and strengthen EU cooperation on vaccine-preventable diseases.

All the reports are available by clicking on the link below.

› Read more

ESCMID Funded Observerships: applications are being accepted from now until 3 December 2018.

You can click on this link (Hyperlink when online) to apply for one of the 50 funded observerships available. The deadline is Monday, 3 December 2018 10:00 AM (CET).

So make sure you get your application to us before then. Donīt forget to pay attention to the criteria and ensure you have all the necessary documents to send with your application. You may also apply for unfunded observerships via this link.

If you have any questions, please contact observerships@escmid.org. The next call for funded observerships will be announced in Spring 2019

› Read more

ECCMID Abstract submission is open!

Submission of abstracts for ECCMID 2019 is open, and will close on 28 November 2018.

› Read more

ESCMID generic competencies in antimicrobial prescribing and stewardship

ESCMID has developed a set of generic competencies in antimicrobial prescribing and stewardship, through a structured Europe-wide consensus procedure. These competencies represent the minimum standards that all independent prescribers of antimicrobials should reach to practise according to the principles of responsible antimicrobial use and are intended to be relevant for all independent prescribers in Europe.

The list of generic competencies can be downloaded here. The set includes 35 competency points, in three sections: Core concepts in microbiology, pathogenesis and diagnosing infections; Antimicrobial prescribing; Antimicrobial stewardship. The manuscript describing the study has been published in Clinical Microbiology and Infection.

› Read more

CMI highlight: results of a cluster randomised feasibility trial of on-site rapid Chlamydia trachomatis tests and treatment in London, UK

Oakeshott et al conducted a cluster-randomised feasibility trial of the 90-minute Chlamydia trachomatis tests with same day on-site treatment (“Test n Treat/TnT”) in six technical colleges in London (UK) to assess TnT uptake and follow-up rates, prevalence of C.trachomatis at baseline and 7-months, time to treatment and acceptability of TnT. The study included sexually active students (n=509) of whom 55% reported ≥2 sexual partners in the previous year. TnT uptake was 13% (33/259; 95% CI 8.9-17.4%) at one month and 10% (26/259;6.7-14.4%) at 4-months with overall C.trachomatis positivity 5.1% (3/59;1.1-14.2%). Follow-up at 7-months was 62% (317/509) for questionnaires and 52% (264/509) for samples. C.trachomatis prevalence was 6.3% (31/503) at baseline and 6.1% (16/264) at 7-months. Median time from test-to-treatment was 15-hours. Interviews suggested low test uptake was associated with not feeling at risk, perceptions of stigma and little knowledge of sexually transmitted infections (STIs). The authors conclude that despite high C.trachomatis rates at baseline and follow-up, uptake of testing was low. Like many countries, England urgently needs better sex education, including making STI testing routine/normal.

› Read more

Register now for a websymposium on preclinical toxicology of antibiotics

The Global Antibiotic R&D Partnership (GARDP) has created REVIVE to connect and support the antimicrobial discovery, research, and development community. On 13 November, 17:00 – 18:30 CET (find your time zone here), GARDP will broadcast a websymposium with Claire Sadler. After viewing Claire’s presentation “Making Safety a Part of Drug Design” from the GARDP/CARB-X co-organized “Antibiotic Bootcamp for Developers: Preclinical Toxicology” at the ESCMID/ASM Conference to Meet the Challenge of Antimicrobial Resistance 2018, you will have the chance to ask your questions in an interactive Q&A session.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.